EDC 2014 SR (UPDATED)

EDC 2014 Performance Report
Assets Carried at Amortized Cost
For assets carried at amortized cost, the Company first assesses whether an objective evidence of
impairment exists individually for financial assets that are individually significant, or collectively
for financial assets that are individually and not individually significant. If the Company
determines that no objective evidence of impairment exists for individually assessed financial
asset, whether significant or not, it includes the asset in a group of financial assets with similar
credit risk characteristics and collectively assesses for impairment. Those characteristics are
relevant to the estimation of future cash flows for groups of such assets by being indicative of the
debtors’ ability to pay all amounts due according to the contractual terms of the assets being
evaluated. Assets that are individually assessed for impairment and for which an impairment loss
is, or continues to be, recognized are not included in a collective assessment for impairment.
If there is an objective evidence that an impairment loss has been incurred, the amount of loss is
measured as the difference between the asset’s carrying value and the present value of the
estimated future cash flows (excluding future credit losses that have not been incurred) discounted
at the financial assets’ original effective interest rate which is the effective interest rate computed
at initial recognition. The carrying value of the asset is reduced through the use of an allowance
account and the amount of loss is recognized in the consolidated statement of income. If in case
the receivable has proven to have no realistic prospect of future recovery, any allowance provided
for such receivable is written off against the carrying value of the impaired receivable. If, in a
subsequent year, the amount of the estimated impairment loss decreases because of an event
occurring after the impairment was recognized, the previously recognized impairment loss is
reduced by adjusting the allowance account. Any subsequent reversal of an impairment loss is
recognized in the consolidated statement of income, to the extent that the carrying value of the
asset does not exceed its amortized cost at reversal date.
AFS Investments
For AFS investments, the Company assesses at each financial reporting date whether there is
objective evidence that a financial asset or group of financial assets is impaired.
In the case of equity investments classified as AFS, impairment indicators would include a
significant or prolonged decline in the fair value of the investments below its cost. Where there is
evidence of impairment, the cumulative loss, measured as the difference between the acquisition
cost and the current fair value, less any impairment loss on that financial asset previously
recognized in the consolidated statement of comprehensive income, is removed from equity and
recognized in the consolidated statement of income. Impairment losses on equity investments are
not reversed through the consolidated statement of income. Increases in fair value after
impairment are recognized directly in the consolidated statement of comprehensive income.
In the case of debt instruments classified as AFS investments, impairment is assessed based on the
same criteria as financial assets carried at amortized cost. Future interest income is based on the
reduced carrying amount and is accrued based on the rate of interest used to discount future cash
flows for the purpose of measuring impairment loss. Such accrual is recorded as part of “Interest
income” in the consolidated statement of income. If, in a subsequent year, the fair value of a debt
instrument increases and that increase can be objectively related to an event occurring after the
impairment loss was recognized in the consolidated statement of income, the impairment loss is
reversed through the consolidated statement of income.
173